Please use this identifier to cite or link to this item:
Title: Mycophenolate mofetil inhibits intimal hyperplasia and attenuates the expression of genes favouring smooth muscle cell proliferation and migration.
Authors: Waller, JR
Brook, NR
Bicknell, GR
Murphy, GJ
Nicholson, ML
First Published: Jan-2005
Citation: TRANSPLANT PROC, 2005, 37 (1), pp. 164-166
Abstract: Intimal hyperplasia remains the leading cause of late graft failure following heart transplantation. The immunosuppressive drug mycophenolate mofetil has been shown to inhibit the development of intimal hyperplasia. This study aimed to assess the efficacy of a combination of mycophenolate mofetil, calcineurin inhibition, and sirolimus on the development of intimal hyperplasia.
DOI Link: 10.1016/j.transproceed.2005.01.049
ISSN: 0041-1345
Type: Journal Article
Appears in Collections:Published Articles, Dept. of Infection, Immunity and Inflammation

Files in This Item:
There are no files associated with this item.

Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.